Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Journal of Dentistry|December 16, 2017
Potassium oxalate oral rinses for long-term relief from dentinal hypersensitivity: Three randomised controlled studiesGary R Burnett, John T Gallob, Kimberly R Milleman, et al.
International Journal of Endocrinology and Metabolism|April 5, 2021
Effect of Correction of Hyperthyroidism with Anti-thyroid Drugs on the Glycated Hemoglobin in Non-diabetic Patients with Primary HyperthyroidismDasari Mani Deepthi, Suresh Vaikkakara, Avinash Patil, et al.
Chemical Engineering Journal (Lausanne, Switzerland : 1996)|March 3, 2021
Needleless electrospun phytochemicals encapsulated nanofibre based 3-ply biodegradable mask for combating COVID-19 pandemicNikhil Avinash Patil, Prakash Macchindra Gore, Niranjana Jaya Prakash, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|September 24, 2011
Effect of macronutrients, age, and obesity on 6- and 24-h postprandial glucose metabolism in catsMargarethe Hoenig, Erin T Jordan, John Glushka, et al.
Infection and Immunity|June 23, 2006
Cell wall-mediated neuronal damage in early sepsisCarlos J Orihuela, Sophie Fillon, S Hope Smith-Sielicki, et al.
The Lancet. Infectious Diseases|December 12, 2022
TLR7 agonist RO7020531 versus placebo in healthy volunteers and patients with chronic hepatitis B virus infection: a randomised, observer-blind, placebo-controlled, phase 1 trialMan-Fung Yuen, Rozalina Balabanska, Emmanuelle Cottreel, et al.
Cardiovascular Diabetology|August 23, 2024
Diagnostic and prognostic value of triglyceride glucose index: a comprehensive evaluation of meta-analysisSandeep Samethadka Nayak, Dona Kuriyakose, Lakshmi D Polisetty, et al.
JHEP Reports : Innovation in Hepatology|July 15, 2026
Outcomes of nucleos(t)ide analogue discontinuation following finite xalnesiran-based therapies in chronic hepatitis BCong Cheng, Qing Xie, Edward Gane, et al.
The New England Journal of Medicine|January 8, 2025
Xalnesiran with or without an Immunomodulator in Chronic Hepatitis BJinlin Hou, Wenhong Zhang, Qing Xie, et al.
Pageof 3